FindMyRecallSubscribe
Class I: serious health riskTerminated

Hospira 1% LIDOCAINE HCl Injection Recall

1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL Single-dose vials,…

Hospira Inc. · Lake Forest, IL

Risk level
Class I
Reported by FDA
Feb 11, 2015
Recall ID
D-0382-2015
Check your lot numberHow we source this data

Summary

Hospira recalled 1% LIDOCAINE HCl Injection starting Apr 18, 2014. The FDA classified it as Class I (serious health risk) and published enforcement report D-0382-2015 on Feb 11, 2015. Reason: Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution.

Product description

1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL Single-dose vials, packaged in 25-count cartons, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-4279-02.

Lot numbers, UPCs & expiration codes

Lot number: 31-427-DK, Exp 01JUL2015.

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0382-2015
Classification
Class I
Status
Terminated
Recall initiated
Apr 18, 2014
FDA report date
Feb 11, 2015
Quantity
120,900 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-0382-2015, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
69327
Address
375 N Field Dr
Code information
Lot number: 31-427-DK, Exp 01JUL2015.
Postal code
60045-2513
Report date
Feb 11, 2015
Product type
Drugs
Recall number
D-0382-2015
Classification
Class I
Recalling firm
Hospira Inc.
Product quantity
120,900 vials
Termination date
Nov 7, 2017
Reason for recall
Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL Single-dose vials, packaged in 25-count cartons, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-4279-02.
Distribution pattern
Nationwide.
Recall initiation date
Apr 18, 2014
Initial firm notification
Press Release
Center classification date
Jan 30, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0382-2015, published Feb 11, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls